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1
2 Objectives. UK exercise referral schemes (ERSs) have been criticised for focusing too much on exercise 
3 prescription and not enough on sustainable physical activity (PA) behaviour change.  Previously, a 
4 theoretically-grounded intervention (Co-PARS) was co-produced to support long-term PA behaviour 
5 change in individuals with health conditions. The purpose of this study was to investigate the 
6 effectiveness of Co-PARS compared to a usual care ERS and no treatment for increasing 
7 cardiorespiratory fitness. 
8 Design. A three-arm quasi-experimental trial. 
9 Setting. Two leisure centres providing a) Co-PARS, b) usual exercise referral care, and one no-
10 treatment control. 
11 Participants. 68 adults with lifestyle-related health conditions (e.g. cardiovascular, diabetes, 
12 depression) were recruited to Co-PARS, usual care, or no treatment.
13 Intervention. 16-weeks of physical activity behaviour change support delivered at 4, 8, 12, and 18 
14 weeks, in addition to the usual care 12-week leisure centre access. 
15 Outcome measures. Cardiorespiratory fitness, vascular health, PA, and mental wellbeing were 
16 measured at baseline, 12 weeks, and 6 months (PA and mental wellbeing only). Fitness centre 
17 engagement (Co-PARS and usual care) and behaviour change consultation attendance (Co-PARS) were 
18 assessed. Following an intention-to-treat approach, repeated-measures linear mixed models were 
19 used to explore intervention effects.
20 Results. Significant improvements in cardiorespiratory fitness (p=.002) and vascular health (p=.002) 
21 were found in Co-PARS compared to usual care and no-treatment at 12 weeks. No significant changes 
22 in PA or wellbeing at 12 weeks or 6 months were noted. Intervention engagement was higher in Co-
23 PARS than usual care, though this was not statistically significant.
24 Conclusion. A co-produced PA behaviour change intervention led to promising improvements in 
25 cardiorespiratory and vascular health at 12 weeks, despite no effect for PA levels at 12 weeks or 6 
26 months. 
27
28 Trial registration: ClinicalTrials.gov: NCT03490747
29
30 Keywords: Cardiovascular Health; Self-Determination Theory; Exercise Referral; Behaviour Change 
31 Intervention; Translational Research. 
32
33
34
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1
2 Strengths and limitations of the study
3  This study advances the literature on exercise referral effectiveness by pragmatically evaluating a 
4 co-produced physical activity referral intervention, which was underpinned by multiple 
5 stakeholders and behaviour change theory. 
6  The study documents the third phase of a novel and iterative approach which co-produced, 
7 piloted, and then evaluated (this study) a physical activity referral intervention that was deemed 
8 feasible to implement in practice. 
9  Objective and subjective measures provide insight into the potential effects for patient health. 
10  It is not possible to directly attribute intervention effects to the phased co-production approach, 
11 although supported by the Medical Research Council. 
12  A larger sample size is needed to substantiate findings. 
13
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1 We would like to thank the participants in this study for their time, the delivery staff and centre 
2 managers for their ongoing support, and the initial development group involved in the co-production 
3 process.
4
5 INTRODUCTION
6 Physical inactivity is the fourth leading cause of death worldwide and costs the UK an estimated £7.4 
7 billion annually, including £0.9 billion to the NHS alone[1]. Exercise referral schemes (ERSs) provide a 
8 promising framework to facilitate physical activity (PA) behaviour change in at-risk populations. 
9 Typically, UK ERSs consist of a referral from a healthcare professional to a 12-16-week tailored exercise 
10 programme provided by a qualified practitioner.
11 There is inconsistent evidence as to the effectiveness of ERSs on PA behaviour, mental well-being, 
12 quality of life, and physical health outcomes [2–4]. More recently, however, promising effects of ERSs 
13 have been demonstrated in Wales [5], Sweden [6], and Spain [7] and a systematic review identified 
14 promising effects of UK ERSs on self-reported PA and cardiovascular health markers [8]. Prior and 
15 colleagues [9] demonstrated that for every 11 participants referred to a 24-week ERS, 1 participant 
16 went on to report achieving ≥90 min/week of PA at 12-months. For perspective, it is estimated that 
17 67-167 patients (categorised as <10% cardiovascular disease (CVD) risk)  need to receive statin 
18 treatment for 5 years to prevent one major vascular event [10]. Whilst we are not suggesting PA 
19 behaviour change is a comparable outcome to a serious clinical event, it is notable that replacing 30 
20 minutes of TV viewing time with PA across the UK population, could reduce premature mortality by 
21 5-15%, depending on activity intensity [11]. The majority of studies evaluating ERSs, however, have 
22 drawn on self-reported PA data and future studies employing device-based measures are needed to 
23 substantiate these observations. 
24 Despite recent promise for the effectiveness of ERSs [7–9,12], substantial heterogeneity exists in both 
25 design and delivery [13,14], reflecting varying assumptions on how best to promote health behaviour 
26 change [15,16]. This limits potential scalability of ‘successful’ ERSs. Traditionally, ERSs have focussed 
27 on short-term exercise prescription without appropriate evidence of effectiveness or underpinning of 
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1 behaviour change theory [17]. A recent attempt to integrate behaviour change theory into an ERS [18] 
2 however, showed no advantage over a standard ERS at 12 weeks or 6 months. The authors noted 
3 considerable implementation challenges when training staff, such as work-related demands that may 
4 have reduced the importance of the theory-based training. It is plausible that delivery staff asked to 
5 implement interventions designed by academics may lack ownership and feel less 
6 motivated/competent. One potential way to promote ownership and engagement might be to adopt 
7 a co-production approach, as a means of co-creating value across the public sector [19–21]. Though 
8 not a panacea, the involvement of practitioners, managers and service-users in co-production has 
9 potential to improve intervention relevance, fidelity, and effectiveness [22]. 
10 Previously, a theoretically-grounded PA referral scheme (Co-PARS) was co-produced by academics, 
11 policy-makers, practitioners, and service-users [23] in Liverpool, UK, with a focus on supporting 
12 sustainable PA behaviour change. Liverpool is the 3rd most deprived local authority in England and 
13 has the 2nd highest proportion of Lower Super Output Areas (LSOAs) in the most deprived 10% 
14 nationally [24].  Interventional work with at-risk patients is therefore critical and is aligned with the 
15 concept of proportionate universalism [25]. Underpinned by self-determination theory [24], the co-
16 produced intervention differed from usual ERS care in its focus on PA behaviour change (rather than 
17 exercise prescription), and inclusion of frequent one-to-one consultations with exercise referral 
18 practitioners (compared to usual care which included formal contact at induction only).  A pilot of Co-
19 PARS [26] showed clinically meaningful improvements in cardiorespiratory fitness (CRF) and PA, 
20 although as we did not include a usual care control, it was unknown whether these effects were due 
21 to the fact participants were taking part in an ERS or due to the unique elements of Co-PARS.   
22 Furthermore, despite having very low CRF (<27.7 ml.kg-1.min-1) [26] we found 64% of the baseline pilot 
23 sample were meeting the PA guidelines [27] of at least 150 minutes moderate-intensity PA per week 
24 (measured objectively via accelerometry). This suggested CRF may be a more appropriate primary 
25 outcome measure than PA for this low-fit population (whilst changing PA behaviour was the focus of 
26 the intervention, a target health outcome of this behaviour change was improved CRF). The pilot also 
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1 allowed the opportunity to investigate delivery processes, and we noted several areas that required 
2 refinement in preparation for a controlled trial. These refinements included, increasing the number 
3 of behaviour change consultations from four to five; enhanced focus on daily PA opportunities (rather 
4 than focussing on activities offered at the fitness centre); adapting staff timetables to promote 
5 consistency of care and to allow participant one-to-one consultations to take place in a private room; 
6 and reducing practitioner paperwork. Building on our previous pilot work, the aim of the current study 
7 was to investigate the effectiveness of Co-PARS compared to a usual care ERS and a no-treatment 
8 control on change in cardiorespiratory fitness (CRF) at 12 weeks and PA and wellbeing at 6 months.  
9 METHODS
10 Study Design
11 A three-arm quasi-experimental trial involving: 1. Co-PARS (delivered at fitness centre A); 2. usual care 
12 ERS (delivered at fitness centre B); and 3. no-treatment control.  This paper reports trial outcomes 
13 (CRF, vascular health, PA, mental wellbeing) measured at baseline, 12 weeks, and 6 months (PA and 
14 mental wellbeing only). Additional data were collected to investigate psychosocial processes of 
15 change, intervention fidelity and cost-effectiveness; due to space limitations they are not considered 
16 in the present manuscript, but findings can be obtained on request from p.m.watson@ljmu.ac.uk. Full 
17 written consent was obtained from participants and the study was approved by NHS Research Ethics 
18 Committee (REC: 18/NW/0039 - Project: 238547) and registered on ClinicalTrials.gov (NCT03490747). 
19 Patient and Public Involvement
20 The intervention was previously co-produced, piloted, and adapted with substantial service user input 
21 [23,26]. 
22 Participants and Recruitment 
23 Inclusion criteria were the same for all three conditions (Co-PARS, usual care, no-treatment).  
24 Participants were eligible if aged ≥18 years with a health-related risk factor (e.g. hypertension, 
25 hyperglycaemia, obesity) and/or health condition (e.g. diabetes, cardiovascular disease, depression) 
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1 that may be alleviated by increasing PA levels. Participants with uncontrolled health conditions, severe 
2 psychological or neurological conditions were excluded. Participants for the Co-PARS and usual care 
3 arms were recruited from fitness centre A (Co-PARS) and fitness centre B (usual care) respectively 
4 (where they had been referred for exercise by a health professional). Reception staff at both centres 
5 provided study information and gained consent to pass participant details to the researcher. 
6 Participants for the no-treatment control were recruited via posters, electronic invitations, and email 
7 communications primarily at the university site.  Participants were not eligible for the no-treatment 
8 control if they were currently attending an exercise referral scheme. Interested participants for all 
9 groups were sent an information sheet and baseline data collection was arranged. 
10 Study Arms
11 Intervention arm components are presented in Figure 1.
12 Usual care exercise referral scheme (ERS – centre B). Usual care followed a standard ERS model of 12-
13 week subsidised access to a fitness centre (swimming, gym, group classes). Participants met an 
14 exercise referral practitioner for an initial, 1-hour induction (week 1) during which a 12-week exercise 
15 programme was provided for the participant. Any further contact with a practitioner was informal and 
16 opportunistic. This system was already in place and was considered usual care for the local area. 
17 Centre B was chosen as a comparison centre due to its similarity in referral numbers and socio-
18 economic make-up of the local population to centre A (where Co-PARS was being delivered). For 
19 example, based on areas within Liverpool ranked from 1 (most deprived) to 30 (least deprived), usual 
20 care ERS and Co-PARS were ranked respectively: 20th and 21st (income), 20th and 21st (employment), 
21 22nd and 24th (Education) and 10th and 11th (living environment). 
22 Co-produced PA referral scheme (Co-PARS – centre A)
23 Participants received the same 12-week subsidised access to a fitness centre as usual care plus a series 
24 of one-to-one behaviour change consultations (60-minute induction followed by 30-minute 
25 consultations at weeks 4, 8, 12 and 18). A log book was provided for each participant to set action 
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1 plans, log progress and facilitate consultation discussions. Consultations were delivered by exercise 
2 referral practitioners in an autonomy supportive counselling style, drawing on the principles of self-
3 determination theory [28]. This additional support aimed to encourage habitual opportunities to 
4 increase PA as well as activities available at the fitness centre. A full descripion of the theoretical 
5 underpinning and behaviour change intervention components is available elsewhere [23].
6 Prior to the pilot of Co-PARS [26] practitioners received training in self-determination theory-based 
7 communication strategies led by a sport and exercise psychologist (last author [PMW]), involving a 
8 workshop, one-to-one sessions and follow-up group meetings.  Following the pilot, a further series of 
9 group meetings involving exercise referral practitioners and the research team were held to develop 
10 aspects of delivery that required refinement (as outlined in the introduction).  Full details of the 
11 training are available from p.m.watson@ljmu.ac.uk).    
12 No-treatment control (NTC). Participants received a lifestyle advice booklet only (offered to all study 
13 arms at baseline data collection), based on national guidance for PA, nutrition, smoking cessation and 
14 alcohol consumption. 
15 [INSERT FIGURE 1 SOMEWHERE HERE]
16
17 Outcome measures
18 Primary outcome: Cardio-respiratory fitness (CRF). Maximal oxygen consumption (VO2max-2) was 
19 estimated via the sub-maximal Astrand-Rhyming cycle ergometer protocol [29]. The protocol is a 
20 single-stage cycling test designed to elicit a steady-state heart rate over a period of ~6 minutes. 
21 Accelerometer-derived PA. Tri-axial ActiGraph GT3x accelerometers (ActiGraph, Pensacola, FL, USA) 
22 measured PA for 7 days, which have been validated in a comparable population [30]. Raw triaxial 
23 acceleration values were converted into an omnidirectional measure of acceleration, referred to as 
24 Euclidian norm minus one [31]. Minimum wear time was 10 hours per day and 3 days per week 
25 including one weekend day [32]. The R package GGIR [31] facilitated extraction of user-defined 
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1 acceleration thresholds: 5.9 to 69.1 mg for light-intensity PA [33], 69.1 to 258.7 mg as moderate and 
2 >258.7 mg as vigorous-intensity PA [34].
3 Vascular health. Our previous work has demonstrated carotid artery reactivity (CAR) may be a 
4 promising outcome variable  to assess in PA interventions for at-risk populations [35]. Further, 
5 endothelial function may provide prognostic value beyond that of traditional risk factors [36] with an 
6 increase of 1% in brachial artery flow-mediated dilation (FMD) associated with a 12-15% lower risk of 
7 CV events [33,34]. FMD and CAR were measured using ultrasound techniques [35]. Both techniques 
8 measure vascular endothelial function and have independently predicted future risk of cardiovascular 
9 events in humans [36,37]. Blood pressure was measured in the supine position using an automated 
10 blood pressure device (Omron Healthcare UK Limited, Milton Keynes, UK). 
11 Anthropometric measures. Since obesity is a critical risk factor for poor health and cardiovascular 
12 disease, anthropometric variables were measured to investigate potential intervention effects on 
13 body mass.  Waist-to-height ratio is a stronger predictor of early health risk than Body Mass Index 
14 (BMI) alone [38], therefore we collected both BMI (mass in kg / stature in m2) and waist-to-height 
15 ratio (waist circumference / stature). 
16 Mental wellbeing. As PA is known to enhance mental wellbeing [39] and clinical populations are more 
17 susceptible to mental ill-health [40], it was important to identify whether Co-PARS led to any changes 
18 in mental health (positive or negative). Mental wellbeing was measured using the 14-item Warwick-
19 Edinburgh Mental Well-being Scale (WEMWBS; [41], which asks participants to rate their 
20 psychological wellbeing (e.g. “I’ve been feeling cheerful”) over the previous 2 weeks (measured on a 
21 likert scale of 1 (none of the time) to 5 (all of the time)).
22 Fitness centre engagement (Co-PARS and usual care only). The number of occasions participants 
23 attended the fitness centre between baseline and 12 weeks (weekly attendance) and 12 weeks to 6 
24 months (monthly attendance) was obtained from computerised attendance records.  When 
25 measuring intervention engagement it was deemed inappropriate to calculate the mean number of 
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1 sessions per week, since this could exaggerate the engagement of individuals who attended with 
2 high frequency in the early weeks then dropped out (when compared with individuals who attended 
3 moderately but consistently for the full 12 weeks). Therefore a formula was used to calculate a 
4 percentage for ‘12-week engagement’ (based on the recommended bi-weekly attendance ):
5
6
7
8
9
10 This formula took into account both frequency and consistency of attendance to yield a percentage 
11 score that ranged from 0% (no attendance) to 120% (attendance of three or more times per week 
12 for the whole 12 weeks).   
13 Monthly attendance post-12 weeks was calculated as a mean attendance across months 4 to 6, 
14 therefore did not take consistency of attendance into account.    
15 Behaviour change consultation attendance (Co-PARS only).  The number of consultations offered and 
16 attended were measured by exercise referral practitioners at induction, 4, 8, 12, and 18 weeks.
17 Sample size
18 Sample size was determined to detect a meaningful difference in CRF at 12 weeks based on our pilot 
19 results [26]. To detect a difference of 2 ml.kg-1min-1 between Co-PARS and usual care, 42 participants 
20 were required per arm (f= .25, p= .05, power = .80). To detect a difference of 3.2 ml.kg-1min-1 between 
21 the intervention arms and the no-treatment control, 17 participants were required for the no-
22 treatment control (f= .5, p= .05, power = .80). Thus, a total sample of 101 participants were required.
23 Statistical analyses
24 An intention-to-treat approach was used assuming no change in non-respondents (last observation 
25 carried forward) to produce a conservative estimate of intervention effects. Delta changes (∆) from 
((n1*0.5) + (n2) + (n3*1.2))
12
* 100
n1 = number of weeks in which participant attends once only
n2 = number of weeks in which participant attends twice
n3 = number of weeks in which participant attends three or more times 
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1 pre- to post-intervention were calculated for each group and entered as the dependent variable in 
2 repeated measures linear mixed model analyses.  A random intercept model was used with fixed 
3 effects for study arm (Co-PARS, usual care ERS, no-treatment control) and time (baseline-to-week-12 
4 change, week-12-to-6-month change, and baseline-to-6-month change) and participants included as 
5 random effects. Least squared difference (LSD) was used for post hoc testing. Testing for baseline 
6 differences to identify covariates was avoided, as this method has been demonstrated to inflate bias, 
7 instead pre-intervention was entered into the model as a covariate. Furthermore, all linear mixed 
8 model analyses were repeated with age and employment as covariates as a comparison to the results 
9 presented in this study (with baseline score as a covariate) due to their known prognostic value. Using 
10 age and employment as covariates resulted in no change in inferences presented in this study. One-
11 way ANOVAs were used to compare baseline values between intervention arms. Fitness centre 
12 engagement was determined as described above. Behaviour change consultation attendance is 
13 presented descriptively. For non-normally distributed data, median and interquartile range is 
14 presented and within group median change was calculated via Wilcoxon signed-rank tests.
15 RESULTS
16 Participants. 68 participants provided baseline data, 56 of whom provided 12-week data, and 58 of 
17 whom provided 6-month data (figure 2).  
18 Baseline characteristics (table 1). No significant differences were noted between arms for age, sex, 
19 ethnicity, BMI, referral reason, or accelerometer-derived PA levels (p>.05). Full-time employment 
20 status (p=.001) and CRF (p=.015) were significantly higher in the control compared to usual care and 
21 Co-PARS. Smoking status was significantly higher in usual care compared to Co-PARS and control 
22 (p=.010). Mental wellbeing was significantly lower in Co-PARS compared to control (p=.023). 
23
24 [INSERT FIGURE 2 SOMEWHERE HERE]
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1
2
3
4
5 Baseline-to-12-Week effects
6 Raw outcome values are presented for baseline, week 12, and 6 months in Table 2. There was a 
7 significant effect for study arm in baseline-to-12-week change in CRF (p=.002). Post hoc testing 
Table 1. Baseline characteristics presented as Mean  SD or % (n) of group.
Co-produced PA 
referral
(n=33)
Usual care 
ERS 
(n=19)
No-treatment 
control 
(n=16)
Between 
arm 
p-value
Age (years) 57  12 53  16 48 ± 15 p=.319 
Female (% of sample) 58 (19) 47 (9) 56 (9) p=.774
White British (% of sample) 82 (27) 95 (18) 75 (12) p=.132
Full-time employment (% of sample) 18 (6) 26 (5) 62 (10) p=.001
Never smoked (% of sample) 73 (24) 37 (7) 81 (13) p=.002
Body mass index (kg/m2) 31  7 33  6 29 ± 6 p=.226
Systolic blood pressure (mmHg) 131  11 138  18 123 ± 12 p=.010
Primary referral reason /  health concern (control) p=.132
Cardiometabolic (% of sample) 67 (22) 43 (8) 62 (10) -
Cancer (% of sample) 6 (2) 5 (1) 6 (1) -
Mental Health (% of sample) 18 (6) 26 (5) 19 (3) -
Musculoskeletal (% of sample) 9 (3) 26 (5) 13 (2) -
Comorbidity (% of sample)  85 (28)  100 (19)  81 (13) p=.166
Meeting the PA guidelines (% of 
sample)*
73 (22) 71 (10) 93 (13) p=.223
P-values represent between arm baseline effects. There was no between arm effect for referral reason, thus no between arm p-values are provided for referral reason 
sub groups. 
*Chief Medical Officers’ 2019 physical activity guidelines: 150 minutes of moderate-intensity physical activity per week. 
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1 revealed a significantly higher CRF change in Co-PARS (2.4) compared to the ERS (0.3; p=.021) and 
2 control (-0.6; p=.001), but no difference between the ERS and control (p=.314). A significant effect for 
3 study arm was found in change in FMD% (p=.002), with FMD% change significantly higher in Co-PARS 
4 (2.4) compared to control (-1.1; p=.001) but not the ERS (0.8; p=.099). The change in FMD% was not 
5 significantly different between the ERS and control (p=.71). No statistically significant study arm 
6 effects were noted for changes in CAR%, blood pressure, resting heart rate, anthropometric measures, 
7 PA or WEMWBS at 12 weeks (p>.05). 
8 Baseline-to-6-month effects
9 No statistically significant study arm effects were noted for change in WEMWBS or PA at 6 months 
10 (p>.05). 
11 Fitness centre engagement (Co-PARS and usual care ERS) and consultation attendance (Co-PARS 
12 only). 
13 Table 3 reports the participant fitness centre engagement data for the Co-PARS and usual care ERS. 
14 Although not statistically significant, Co-PARS engagement was 9% higher, participants attended the 
15 fitness centre on average 3 times more per month, and 23% more participants were attending the 
16 fitness centre beyond 6-months follow-up compared to usual care. Co-PARS behaviour change 
17 consultation attendance is reported in Table 4.
18
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Table 2. Cardiometabolic health outcomes and PA levels at baseline, 12 weeks, 6 months, and between arm baseline-to 12-week or 6-month 
effect.  All variables are presented as Mean  SD.
Co-PARS Usual Care ERS No-Treatment Control
Baseline Week 12 6 Month Baseline Week 12 6 Month Baseline Week 12 6 Month Between arm effect p-value(a)
Fitness (n=56)
CRF  ml.kg.-1min-1 22.27 24.67 - 23.36.6 23.67 - 29.69.2 28.98.7 - p=.002
Physical Activity
GT3x (n= 61) Mins.day
Light intensity 9052 9864 10775 9836 9331 158145 9037 10133 8640 p=.332
Moderate intensity 4432 4229 4233 4328 4330 5555 6031 6524 5421 p=.260
Vigorous intensity 13 12 12 12 11 12 24 23 38 p=.108
Vascular Ultrasound (n=64)
CAR% 1.72.7 2.82.2 - 2.71.8 3.92.8 - 2.52.7 1.72.7 - p=.073
CAR Baseline cm 0.690.07 0.690.06 - 0.690.08 0.70.09 - 0.650.07 0.640.06 - p=.130
FMD% 4.42.3 6.82.7 - 4.22 52.1 - 6.22.1 5.22.8 - p=.002
FMD Baseline  cm 0.390.07 0.380.06 - 0.390.09 0.41 0.08 - 0.380.08 0.370.06 - p=.728
Cardiometabolic (n=68)
BMI kg.m2 317 307 - 336 326 - 296 296 - p=.323
WHR 629 6110 - 648 638 - 569 569 - p=.261
SBP mmHg 13111 12712 - 13818 13215 - 12312 11813 - p=.937
DBP  mmHg 737 718 - 739 7111 - 7211 6810 - p=.584
RHR bpm 7010 6510 7012 6811 6612 639 p=.540
Mental Wellbeing (n=68)
WEMWBS 469 5110 4810 4910 5211 5013 539 569 5310 p=.796
 Co-PARS, Co-produced PA referral scheme; ERS, Exercise referral scheme; CRF, Cardiorespiratory Fitness; GT3x, Accelerometer; CAR, Carotid artery reactivity; FMD, Flow-mediated dilation; BMI, Body Mass Index; WHR, 
Waist-to-Height ratio;  SBP, Systolic blood pressure; DBP, Diastolic blood pressure; RHR, Resting heart rate, WEMWBS, Warwick-Edinburgh Mental Wellbeing Scale
a F-statistic for between arm baseline-to-6-month change or baseline-to-week 12 change if variable not collected at 6 months.
Missing data was due to inability to complete the CRF test (n=12), inability to complete the vascular ultrasound protocols (n=4), and insufficient accelerometer wear time or non-return (n=7). 
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Table 3. Fitness centre engagement.
 Co-PARS
(n=33)
Usual Care
(n=19)
Between centre difference
% Engagementa  (Mean  SD) 42±29 33±27 p=.267
Number of fitness centre visits (per person  
per month) week 12 to 6 months (Med, IQR)
3(0-14) 0 (0-1) p=.072
% of baseline sample who attended fitness 
centre at least once beyond 6 months (% of 
sample, n)
39 (13) 16 (3) p=.101
aBased on the formula (((n1*0.5)+(n2)+(n3*1.2))/12) * 100; n1=number of weeks in which participant attends once only; n2=number of weeks in which 
participant attends twice; n3=number of weeks in which participant attends three or more times.  aEngagement;.based on a recommended attendance 
of twice weekly, a formula was used to calculate a percentage for “12-week engagement”, which took into account both frequency and consistency of 
attendance (see methods). 
Table 4. Co-PARS behaviour change consultation attendance (based on baseline sample of 33 
participants).
Consultation % Booked (n) % Attended (n)
Induction 91(30) 93(28)
Week 4 82(27) 78(21)
Week 8 67(22) 91(20)
Week 12 64(21) 81(17)
Week 18 55(18) 50(9)
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1 DISCUSSION
2 This was the first study to investigate the effectiveness of a theoretically-grounded, co-produced PA 
3 referral scheme (Co-PARS) compared to a usual care ERS and no treatment. Despite challenges in 
4 recruitment that meant the study was statistically underpowered, the findings demonstrated 
5 significant and clinically meaningful improvements in CRF and vascular health in Co-PARS compared 
6 to the usual care and no treatment. No statistically significant effects were noted for accelerometer-
7 derived PA levels or mental wellbeing at 12-weeks or 6-months. 
8 The effect of usual care ERSs compared to theoretically-grounded interventions on CRF has not been 
9 previously explored. We observed a significant increase in CRF in Co-PARS compared to usual care and 
10 a no-treatment control. According to values reported by Clausen et al. [42] both Co-PARS (22 ml.kg.-
11 1min-1) and usual care (23 ml.kg.-1min-1) participants were below the lower limit of ‘healthy’ (27.7 
12 ml.kg.-1min-1) for baseline CRF [43]. As low CRF is associated with a substantially elevated risk of all-
13 cause mortality [43], the magnitude of change demonstrated in Co-PARS (2.4 ml.kg.-1min-1) may be 
14 clinically meaningful. For example, in at-risk populations, relatively small magnitudes (≤1 ml.kg.-1min-
15 1) have been shown to significantly reduce clustered cardiometabolic risk [44]. Thus, Co-PARS was 
16 effective at improving CRF in individuals with low CRF by a clinically meaningful amount.
17 Promising improvements in vascular health were also noted in the Co-PARS group, with brachial artery 
18 FMD significantly improved compared to usual care and control arms. Although CAR was not 
19 statistically different between arms, both Co-PARS and usual care demonstrated a potentially 
20 meaningful within-arm improvement compared with no treatment, which exhibited a deterioration in 
21 vascular health. Such improvements in vascular measures may have prognostic implications. For 
22 example, a 1% increase in FMD has been suggested to reduce the future risk of CVD events by 13% 
23 [36].
24 Despite low baseline CRF, a substantial percentage of Co-PARS (73%) and usual care (71%) participants 
25 were meeting the Department of Health [45] guidelines of 150 minutes of moderate-intensity PA per 
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1 week. We observed a similar finding in our pilot [26] and subsequently raised the question as to the 
2 use of PA guidelines to assess eligibility for ERSs (NICE, 2014), as it appears from our data that 
3 individuals classified as “physically active” can still be very unfit and therefore can benefit from ERSs 
4 in terms of improved fitness and cardiometabolic health. A further discrepancy was noted in the lack 
5 of change in PA levels in Co-PARS, despite improved CRF. It is possible measurement issues 
6 contributed to this discrepancy. Accelerometers can measure certain types of PA such as walking, 
7 running, and stair climbing [46]. They may not, however, sufficiently identify activities typical of an 
8 ERS delivered within a fitness centre environment (e.g. cycling, resistance training, circuits, 
9 swimming). Given Co-PARS had higher (albeit non-significant) fitness centre engagement compared 
10 to usual care, it is possible PA changes occurred that were not detected by the accelerometry data. 
11 Consideration therefore needs to be given to the appropriateness of accelerometers to measure PA 
12 in ERSs.  Alternative methods such as heart-rate monitors combined with self-report data may be 
13 worthy of consideration, although further work would be required to develop standardized data 
14 collection and analysis protocols (taking into account the limitations of each of these methods if used 
15 in isolation [47]).  Researchers are therefore urged to consider CRF as a primary outcome in ERSs until 
16 appropriate alternative methods of measuring PA behaviour are developed. Ultimately, it is not clear 
17 why the increase in fitness occurred without a corresponding change in PA and further research is 
18 required to elucidate the relationship between PA and fitness in this population. 
19 In addition to physiological health outcomes, we found baseline mental wellbeing to be below the 
20 national average (score of 50) in both Co-PARS (46) and usual care (49), but not the control (53) [48]. 
21 Despite no significant between-group effect for mental wellbeing, within-group changes at 12 weeks 
22 were deemed clinically meaningful for Co-PARS (5) and usual care (3) but not in the no treatment 
23 control. It is notable that the post-intervention magnitude of change observed in mental wellbeing for 
24 Co-PARS (5) was larger than that observed in a meta-analysis encompassing >23,000 participants 
25 across 13 different ERSs (3), which were comparable in nature to the usual care ERS in this study [49].
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1 From the 6-month data it appeared the scheme was not effective at promoting sustained PA behaviour 
2 change or mental wellbeing improvements. It must be noted, however, that the wellbeing levels were 
3 still higher than baseline and even small magnitudes of change (1-3) may be meaningful in clinical 
4 populations [50]. As discussed earlier, it may be that measuring PA using the methods described in 
5 this study prevented the identification of activities typical of a fitness centre environment. This notion 
6 is supported by the post-week-12 attendance data, which highlighted Co-PARS participants were 
7 regularly attending the fitness centre whereas the usual care participants were not. Challenges of 
8 maintaining sustained health outcomes post-ERSs have been highlighted elsewhere [3]. And whilst a 
9 recent systematic review reported longer length schemes (>20 weeks) may be more effective than 
10 shorter schemes [8], the four long ERSs (20-26 weeks) collected pre-post data only. Thus we do not 
11 know if longer length ERSs result in enhanced health outcomes post intervention compared with 
12 shorter schemes. To determine if longer length schemes are indeed more effective, longer-term 
13 follow-up data collection is required, ideally at 6 and 12 months post intervention [51]. 
14 Through a phased approach we have assessed the effectiveness of Co-PARS resulting from several 
15 years of co-production. Whilst the effects of co-production are difficult to isolate, a comparison of 
16 results at different stages of intervention refinement suggests the phased development approach had 
17 some positive effects. Unpublished engagement data from centre A in 2014-2015 (when the centre 
18 was running a usual care ERS) shows that engagement improved after the introduction of Co-PARS 
19 (42% vs 28% in 2014-2015), whereas engagement reduced in the usual care centre over the same 
20 period (32% vs 37% in 2014-2015).  Furthermore, consultation attendance for Co-PARS in the current 
21 study was substantially higher than in our previous pilot (54% attended induction plus ≥3 behaviour 
22 change consultations, vs 9% in the pilot [26]), which may have been a reflection of refinements made 
23 to the intervention after the pilot (e.g. improved focus on holistic PA, improved monitoring 
24 procedures, improved continuity of instructors). These improvements in engagement highlight the 
25 importance of allowing time for complex interventions to develop [52], and are particularly promising 
26 given the effectiveness of ERSs are highly dependent on participant adherence [5,21]. Furthermore, 
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1 this study has demonstrated how investing in the “bottom-up” development of an intervention can 
2 lead to an effective and sustainable model. We therefore support the arguments of Rutter and 
3 colleagues [53] in that a shift in thinking is needed, instead of asking whether an intervention works 
4 to fix a problem, researchers should aim to identify if and how it contributes to reshaping a system in 
5 a favourable way. As such, we propose the co-production and implementation process may be as 
6 important as the scheme content itself.
7 Methodological considerations
8 This is the first known study to investigate the effectiveness of a co-produced PA referral scheme (Co-
9 PARS) in comparison to usual care and a no-treatment control. Our novel approach addresses an 
10 important gap in the sport and exercise medicine literature [54], in that we employed rigorous 
11 laboratory-based instruments to measure  health outcomes that can be achieved through an 
12 ecologically valid, “real-world” intervention. We observed a very high retention at 6-month follow up, 
13 which may be due in part to the fact many of the participants were retired (and therefore may have 
14 more available time). It is possible also that the high retention was facilitated by the co-production 
15 process, which involved ongoing relationships between the research and delivery teams (and 
16 therefore helped with the logistics of returning accelerometers for the co-PARS and usual care 
17 groups). Whilst this paper highlights many strengths of co-production, we do not wish to present co-
18 production as a panacea [19] and it is important potential challenges and costs are considered prior 
19 to undertaking such an approach [21,22].
20 We must acknowledge some limitations of the study.  Whilst there is a need for high-quality RCTs of 
21 theoretically informed approaches to PA behaviour change [3],  several pragmatic reasons meant an 
22 RCT approach was not appropriate for the present study. Firstly, it was important participants could 
23 choose the most convenient fitness centre. Secondly, it was important we continued work with the 
24 same fitness centre and staff (following co-production [23] and pilot [26] phases) in order to develop 
25 the intervention to the point where it was deemed to have a worthwhile effect [52]. A pragmatic 
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1 research approach was therefore deemed most appropriate to evaluate Co-PARS with high ecological 
2 validity. Pragmatic constraints (e.g. fitness centre refurbishments, staff illness) did however mean the 
3 required sample size was not achieved, thus inferences of effectiveness need to be taken with caution. 
4 This is particularly true for the PA data, where the relatively high variability (compared with CRF) may 
5 have contributed to the lack of change observed in PA in this study. It is recommended future work 
6 considers pragmatic risks and contingencies when planning recruitment and plans sufficient time to 
7 cope with recruitment delays. For pragmatic reasons, not all outcomes were collected at 6-months 
8 follow-up and further research is needed to collect long-term, objective health data following PA 
9 referral schemes.  Finally, it must be noted that while the trial registration appears to be retrospective 
10 (April 6th 2018), the initial submission was several months prior to this (January 11th 2018).  Final sign-
11 off was delayed due to capacity issues within the research team.   
12 CONCLUSION
13 A co-produced, theoretically-grounded PA referral scheme (Co-PARS) led to improved CRF and 
14 vascular health in at-risk individuals when compared to usual care and no treatment. In addition, 
15 clinically meaningful improvements in vascular health and mental wellbeing were observed at 12-
16 weeks in both Co-PARS and usual care, but not the no treatment control group. Of note, PA remained 
17 unchanged at 12-weeks and 6-months follow-up. Adopting a phased approach has enabled multi-
18 stakeholder input and ongoing intervention refinement, resulting in an intervention that showed 
19 promising effects on engagement and clinically meaningful improvements to participant health.  
20
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1 Figure Legends
2 Figure 1. ‘PaT Plot’ describing intervention arm components.[55] 
3 Figure 2. Participant flow diagram within the three study arms (March 2018-January 2019). 
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1
2 Objectives. UK exercise referral schemes (ERSs) have been criticised for focusing too much on exercise 
3 prescription and not enough on sustainable physical activity (PA) behaviour change.  Previously, a 
4 theoretically-grounded intervention (Co-PARS) was co-produced to support long-term PA behaviour 
5 change in individuals with health conditions. The purpose of this study was to investigate the 
6 effectiveness of Co-PARS compared to a usual care ERS and no treatment for increasing 
7 cardiorespiratory fitness. 
8 Design. A three-arm quasi-experimental trial. 
9 Setting. Two leisure centres providing a) Co-PARS, b) usual exercise referral care, and one no-
10 treatment control. 
11 Participants. 68 adults with lifestyle-related health conditions (e.g. cardiovascular, diabetes, 
12 depression) were recruited to Co-PARS, usual care, or no treatment.
13 Intervention. 16-weeks of physical activity behaviour change support delivered at 4, 8, 12, and 18 
14 weeks, in addition to the usual care 12-week leisure centre access. 
15 Outcome measures. Cardiorespiratory fitness, vascular health, PA, and mental wellbeing were 
16 measured at baseline, 12 weeks, and 6 months (PA and mental wellbeing only). Fitness centre 
17 engagement (Co-PARS and usual care) and behaviour change consultation attendance (Co-PARS) were 
18 assessed. Following an intention-to-treat approach, repeated-measures linear mixed models were 
19 used to explore intervention effects.
20 Results. Significant improvements in cardiorespiratory fitness (p=.002) and vascular health (p=.002) 
21 were found in Co-PARS compared to usual care and no-treatment at 12 weeks. No significant changes 
22 in PA or wellbeing at 12 weeks or 6 months were noted. Intervention engagement was higher in Co-
23 PARS than usual care, though this was not statistically significant.
24 Conclusion. A co-produced PA behaviour change intervention led to promising improvements in 
25 cardiorespiratory and vascular health at 12 weeks, despite no effect for PA levels at 12 weeks or 6 
26 months. 
27
28 Trial registration: ClinicalTrials.gov: NCT03490747
29
30 Keywords: Cardiovascular Health; Self-Determination Theory; Exercise Referral; Behaviour Change 
31 Intervention; Translational Research. 
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1
2 Strengths and limitations of the study
3  This study advances the literature on exercise referral effectiveness by pragmatically evaluating a 
4 co-produced physical activity referral intervention, which was underpinned by multiple 
5 stakeholders and behaviour change theory. 
6  The study documents the third phase of a novel and iterative approach which co-produced, 
7 piloted, and then evaluated (this study) a physical activity referral intervention that was deemed 
8 feasible to implement in practice. 
9  Objective and subjective measures provide insight into the potential effects for patient health. 
10  It is not possible to directly attribute intervention effects to the phased co-production approach, 
11 although supported by the Medical Research Council. 
12  A larger sample size is needed to substantiate findings. 
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1 We would like to thank the participants in this study for their time, the delivery staff and centre 
2 managers for their ongoing support, and the initial development group involved in the co-production 
3 process.
4
5 INTRODUCTION
6 Physical inactivity is the fourth leading cause of death worldwide and costs the UK an estimated £7.4 
7 billion annually, including £0.9 billion to the NHS alone[1]. Exercise referral schemes (ERSs) provide a 
8 promising framework to facilitate physical activity (PA) behaviour change in at-risk populations. 
9 Typically, UK ERSs consist of a referral from a healthcare professional to a 12-16-week tailored exercise 
10 programme provided by a qualified practitioner.
11 There is inconsistent evidence as to the effectiveness of ERSs on PA behaviour, mental well-being, 
12 quality of life, and physical health outcomes [2–4]. More recently, however, promising effects of ERSs 
13 have been demonstrated in Wales [5], Sweden [6], and Spain [7] and a systematic review identified 
14 promising effects of UK ERSs on self-reported PA and cardiovascular health markers [8]. Prior and 
15 colleagues [9] demonstrated that for every 11 participants referred to a 24-week ERS, 1 participant 
16 went on to report achieving ≥90 min/week of PA at 12-months. For perspective, it is estimated that 
17 67-167 patients (categorised as <10% cardiovascular disease (CVD) risk)  need to receive statin 
18 treatment for 5 years to prevent one major vascular event [10]. Whilst we are not suggesting PA 
19 behaviour change is a comparable outcome to a serious clinical event, it is notable that replacing 30 
20 minutes of TV viewing time with PA across the UK population, could reduce premature mortality by 
21 5-15%, depending on activity intensity [11]. The majority of studies evaluating ERSs, however, have 
22 drawn on self-reported PA data and future studies employing device-based measures are needed to 
23 substantiate these observations. 
24 Despite recent promise for the effectiveness of ERSs [7–9,12], substantial heterogeneity exists in both 
25 design and delivery [13,14], reflecting varying assumptions on how best to promote health behaviour 
26 change [15,16]. This limits potential scalability of ‘successful’ ERSs. Traditionally, ERSs have focussed 
27 on short-term exercise prescription without appropriate evidence of effectiveness or underpinning of 
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1 behaviour change theory [17]. A recent attempt to integrate behaviour change theory into an ERS [18] 
2 however, showed no advantage over a standard ERS at 12 weeks or 6 months. The authors noted 
3 considerable implementation challenges when training staff, such as work-related demands that may 
4 have reduced the importance of the theory-based training. It is plausible that delivery staff asked to 
5 implement interventions designed by academics may lack ownership and feel less 
6 motivated/competent. One potential way to promote ownership and engagement might be to adopt 
7 a co-production approach, as a means of co-creating value across the public sector [19–21]. Though 
8 not a panacea, the involvement of practitioners, managers and service-users in co-production has 
9 potential to improve intervention relevance, fidelity, and effectiveness [22]. 
10 Previously, a theoretically-grounded PA referral scheme (Co-PARS) was co-produced by academics, 
11 policy-makers, practitioners, and service-users [23] in Liverpool, UK, with a focus on supporting 
12 sustainable PA behaviour change. Liverpool is the 3rd most deprived local authority in England and 
13 has the 2nd highest proportion of Lower Super Output Areas (LSOAs) in the most deprived 10% 
14 nationally [24].  Interventional work with at-risk patients is therefore critical and is aligned with the 
15 concept of proportionate universalism [25]. Underpinned by self-determination theory [24], the co-
16 produced intervention differed from usual ERS care in its focus on PA behaviour change (rather than 
17 exercise prescription), and inclusion of frequent one-to-one consultations with exercise referral 
18 practitioners (compared to usual care which included formal contact at induction only).  A pilot of Co-
19 PARS [26] showed clinically meaningful improvements in cardiorespiratory fitness (CRF) and PA, 
20 although as we did not include a usual care control, it was unknown whether these effects were due 
21 to the fact participants were taking part in an ERS or due to the unique elements of Co-PARS.   
22 Furthermore, despite having very low CRF (<27.7 ml.kg-1.min-1) [26] we found 64% of the baseline pilot 
23 sample were meeting the PA guidelines [27] of at least 150 minutes moderate-intensity PA per week 
24 (measured objectively via accelerometry). This suggested CRF may be a more appropriate primary 
25 outcome measure than PA for this low-fit population (whilst changing PA behaviour was the focus of 
26 the intervention, a target health outcome of this behaviour change was improved CRF). The pilot also 
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1 allowed the opportunity to investigate delivery processes, and we noted several areas that required 
2 refinement in preparation for a controlled trial. These refinements included, increasing the number 
3 of behaviour change consultations from four to five; enhanced focus on daily PA opportunities (rather 
4 than focussing on activities offered at the fitness centre); adapting staff timetables to promote 
5 consistency of care and to allow participant one-to-one consultations to take place in a private room; 
6 and reducing practitioner paperwork. Building on our previous pilot work, the aim of the current study 
7 was to investigate the effectiveness of Co-PARS compared to a usual care ERS and a no-treatment 
8 control on change in cardiorespiratory fitness (CRF) at 12 weeks and PA and wellbeing at 6 months.  
9 METHODS
10 Study Design
11 A three-arm quasi-experimental trial involving: 1. Co-PARS (delivered at fitness centre A); 2. usual care 
12 ERS (delivered at fitness centre B); and 3. no-treatment control.  This paper reports trial outcomes 
13 (CRF, vascular health, PA, mental wellbeing) measured at baseline, 12 weeks, and 6 months (PA and 
14 mental wellbeing only). Additional data were collected to investigate psychosocial processes of 
15 change, intervention fidelity and cost-effectiveness; due to space limitations they are not considered 
16 in the present manuscript, but findings can be obtained on request from p.m.watson@ljmu.ac.uk. Full 
17 written consent was obtained from participants and the study was approved by NHS Research Ethics 
18 Committee (REC: 18/NW/0039 - Project: 238547) and registered on ClinicalTrials.gov (NCT03490747). 
19 Patient and Public Involvement
20 The intervention was previously co-produced, piloted, and adapted with substantial service user input 
21 [23,26]. 
22 Participants and Recruitment 
23 Inclusion criteria were the same for all three conditions (Co-PARS, usual care, no-treatment).  
24 Participants were eligible if aged ≥18 years with a health-related risk factor (e.g. hypertension, 
25 hyperglycaemia, obesity) and/or health condition (e.g. diabetes, cardiovascular disease, depression) 
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1 that may be alleviated by increasing PA levels. Participants with uncontrolled health conditions, severe 
2 psychological or neurological conditions were excluded. Participants for the Co-PARS and usual care 
3 arms were recruited from fitness centre A (Co-PARS) and fitness centre B (usual care) respectively 
4 (where they had been referred for exercise by a health professional). Reception staff at both centres 
5 provided study information and gained consent to pass participant details to the researcher. 
6 Participants for the no-treatment control were recruited via posters, electronic invitations, and email 
7 communications primarily at the university site.  Participants were not eligible for the no-treatment 
8 control if they were currently attending an exercise referral scheme. Interested participants for all 
9 groups were sent an information sheet and baseline data collection was arranged. 
10 Study Arms
11 Intervention arm components are presented in Figure 1.
12 Usual care exercise referral scheme (ERS – centre B). Usual care followed a standard ERS model of 12-
13 week subsidised access to a fitness centre (swimming, gym, group classes). Participants met an 
14 exercise referral practitioner for an initial, 1-hour induction (week 1) during which a 12-week exercise 
15 programme was provided for the participant. Any further contact with a practitioner was informal and 
16 opportunistic. This system was already in place and was considered usual care for the local area. 
17 Centre B was chosen as a comparison centre due to its similarity in referral numbers and socio-
18 economic make-up of the local population to centre A (where Co-PARS was being delivered). For 
19 example, based on areas within Liverpool ranked from 1 (most deprived) to 30 (least deprived), usual 
20 care ERS and Co-PARS were ranked respectively: 20th and 21st (income), 20th and 21st (employment), 
21 22nd and 24th (Education) and 10th and 11th (living environment). 
22 Co-produced PA referral scheme (Co-PARS – centre A)
23 Participants received the same 12-week subsidised access to a fitness centre as usual care plus a series 
24 of one-to-one behaviour change consultations (60-minute induction followed by 30-minute 
25 consultations at weeks 4, 8, 12 and 18). A log book was provided for each participant to set action 
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1 plans, log progress and facilitate consultation discussions. Consultations were delivered by exercise 
2 referral practitioners in an autonomy supportive counselling style, drawing on the principles of self-
3 determination theory [28]. This additional support aimed to encourage habitual opportunities to 
4 increase PA as well as activities available at the fitness centre. A full descripion of the theoretical 
5 underpinning and behaviour change intervention components is available elsewhere [23].
6 Prior to the pilot of Co-PARS [26] practitioners received training in self-determination theory-based 
7 communication strategies led by a sport and exercise psychologist (last author [PMW]), involving a 
8 workshop, one-to-one sessions and follow-up group meetings.  Following the pilot, a further series of 
9 group meetings involving exercise referral practitioners and the research team were held to develop 
10 aspects of delivery that required refinement (as outlined in the introduction).  Full details of the 
11 training are available from p.m.watson@ljmu.ac.uk).    
12 No-treatment control (NTC). Participants received a lifestyle advice booklet only (offered to all study 
13 arms at baseline data collection), based on national guidance for PA, nutrition, smoking cessation and 
14 alcohol consumption. 
15 [INSERT FIGURE 1 SOMEWHERE HERE]
16
17 Outcome measures
18 Primary outcome: Cardio-respiratory fitness (CRF). Maximal oxygen consumption (VO2max-2) was 
19 estimated via the sub-maximal Astrand-Rhyming cycle ergometer protocol [29]. The protocol is a 
20 single-stage cycling test designed to elicit a steady-state heart rate over a period of ~6 minutes. 
21 Accelerometer-derived PA. Tri-axial ActiGraph GT3x accelerometers (ActiGraph, Pensacola, FL, USA) 
22 measured PA for 7 days, which have been validated in a comparable population [30]. Raw triaxial 
23 acceleration values were converted into an omnidirectional measure of acceleration, referred to as 
24 Euclidian norm minus one [31]. Minimum wear time was 10 hours per day and 3 days per week 
25 including one weekend day [32]. The R package GGIR [31] facilitated extraction of user-defined 
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1 acceleration thresholds: 5.9 to 69.1 mg for light-intensity PA [33], 69.1 to 258.7 mg as moderate and 
2 >258.7 mg as vigorous-intensity PA [34].
3 Vascular health. Our previous work has demonstrated carotid artery reactivity (CAR) may be a 
4 promising outcome variable  to assess in PA interventions for at-risk populations [35]. Further, 
5 endothelial function may provide prognostic value beyond that of traditional risk factors [36] with an 
6 increase of 1% in brachial artery flow-mediated dilation (FMD) associated with a 12-15% lower risk of 
7 CV events [33,34]. FMD and CAR were measured using ultrasound techniques [35]. Both techniques 
8 measure vascular endothelial function and have independently predicted future risk of cardiovascular 
9 events in humans [36,37]. Blood pressure was measured in the supine position using an automated 
10 blood pressure device (Omron Healthcare UK Limited, Milton Keynes, UK). 
11 Anthropometric measures. Since obesity is a critical risk factor for poor health and cardiovascular 
12 disease, anthropometric variables were measured to investigate potential intervention effects on 
13 body mass.  Waist-to-height ratio is a stronger predictor of early health risk than Body Mass Index 
14 (BMI) alone [38], therefore we collected both BMI (mass in kg / stature in m2) and waist-to-height 
15 ratio (waist circumference / stature). 
16 Mental wellbeing. As PA is known to enhance mental wellbeing [39] and clinical populations are more 
17 susceptible to mental ill-health [40], it was important to identify whether Co-PARS led to any changes 
18 in mental health (positive or negative). Mental wellbeing was measured using the 14-item Warwick-
19 Edinburgh Mental Well-being Scale (WEMWBS; [41], which asks participants to rate their 
20 psychological wellbeing (e.g. “I’ve been feeling cheerful”) over the previous 2 weeks (measured on a 
21 likert scale of 1 (none of the time) to 5 (all of the time)).
22 Fitness centre engagement (Co-PARS and usual care only). The number of occasions participants 
23 attended the fitness centre between baseline and 12 weeks (weekly attendance) and 12 weeks to 6 
24 months (monthly attendance) was obtained from computerised attendance records.  When 
25 measuring intervention engagement it was deemed inappropriate to calculate the mean number of 
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1 sessions per week, since this could exaggerate the engagement of individuals who attended with 
2 high frequency in the early weeks then dropped out (when compared with individuals who attended 
3 moderately but consistently for the full 12 weeks). Therefore a formula was used to calculate a 
4 percentage for ‘12-week engagement’ (based on the recommended bi-weekly attendance ):
5
6
7
8
9
10 This formula took into account both frequency and consistency of attendance to yield a percentage 
11 score that ranged from 0% (no attendance) to 120% (attendance of three or more times per week 
12 for the whole 12 weeks).   
13 Monthly attendance post-12 weeks was calculated as a mean attendance across months 4 to 6, 
14 therefore did not take consistency of attendance into account.    
15 Behaviour change consultation attendance (Co-PARS only).  The number of consultations offered and 
16 attended were measured by exercise referral practitioners at induction, 4, 8, 12, and 18 weeks.
17 Sample size
18 Sample size was determined to detect a meaningful difference in CRF at 12 weeks based on our pilot 
19 results [26]. To detect a difference of 2 ml.kg-1min-1 between Co-PARS and usual care, 42 participants 
20 were required per arm (f= .25, p= .05, power = .80). To detect a difference of 3.2 ml.kg-1min-1 between 
21 the intervention arms and the no-treatment control, 17 participants were required for the no-
22 treatment control (f= .5, p= .05, power = .80). Thus, a total sample of 101 participants were required.
23 Statistical analyses
24 An intention-to-treat approach was used assuming no change in non-respondents (last observation 
25 carried forward) to produce a conservative estimate of intervention effects. Delta changes (∆) from 
((n1*0.5) + (n2) + (n3*1.2))
12
* 100
n1 = number of weeks in which participant attends once only
n2 = number of weeks in which participant attends twice
n3 = number of weeks in which participant attends three or more times 
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1 pre- to post-intervention were calculated for each group and entered as the dependent variable in 
2 repeated measures linear mixed model analyses.  A random intercept model was used with fixed 
3 effects for study arm (Co-PARS, usual care ERS, no-treatment control) and time (baseline-to-week-12 
4 change, week-12-to-6-month change, and baseline-to-6-month change) and participants included as 
5 random effects. Least squared difference (LSD) was used for post hoc testing. Testing for baseline 
6 differences to identify covariates was avoided, as this method has been demonstrated to inflate bias, 
7 instead pre-intervention was entered into the model as a covariate. Furthermore, all linear mixed 
8 model analyses were repeated with age and employment as covariates as a comparison to the results 
9 presented in this study (with baseline score as a covariate) due to their known prognostic value. Using 
10 age and employment as covariates resulted in no change in inferences presented in this study. One-
11 way ANOVAs were used to compare baseline values between intervention arms. Fitness centre 
12 engagement was determined as described above. Behaviour change consultation attendance is 
13 presented descriptively. For non-normally distributed data, median and interquartile range is 
14 presented and within group median change was calculated via Wilcoxon signed-rank tests.
15 RESULTS
16 Participants. 68 participants provided baseline data, 56 of whom provided 12-week data, and 58 of 
17 whom provided 6-month data (figure 2).  
18 Baseline characteristics (table 1). No significant differences were noted between arms for age, sex, 
19 ethnicity, BMI, referral reason, or accelerometer-derived PA levels (p>.05). Full-time employment 
20 status (p=.001) and CRF (p=.015) were significantly higher in the control compared to usual care and 
21 Co-PARS. Smoking status was significantly higher in usual care compared to Co-PARS and control 
22 (p=.010). Mental wellbeing was significantly lower in Co-PARS compared to control (p=.023). 
23
24 [INSERT FIGURE 2 SOMEWHERE HERE]
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1
2
3
4
5 Baseline-to-12-Week effects
6 Raw outcome values are presented for baseline, week 12, and 6 months in Table 2. There was a 
7 significant effect for study arm in baseline-to-12-week change in CRF (p=.002). Post hoc testing 
Table 1. Baseline characteristics presented as Mean  SD or % (n) of group.
Co-produced PA 
referral
(n=33)
Usual care 
ERS 
(n=19)
No-treatment 
control 
(n=16)
Between 
arm 
p-value
Age (years) 57  12 53  16 48 ± 15 p=.319 
Female (% of sample) 58 (19) 47 (9) 56 (9) p=.774
White British (% of sample) 82 (27) 95 (18) 75 (12) p=.132
Full-time employment (% of sample) 18 (6) 26 (5) 62 (10) p=.001
Never smoked (% of sample) 73 (24) 37 (7) 81 (13) p=.002
Body mass index (kg/m2) 31  7 33  6 29 ± 6 p=.226
Systolic blood pressure (mmHg) 131  11 138  18 123 ± 12 p=.010
Primary referral reason /  health concern (control) p=.132
Cardiometabolic (% of sample) 67 (22) 43 (8) 62 (10) -
Cancer (% of sample) 6 (2) 5 (1) 6 (1) -
Mental Health (% of sample) 18 (6) 26 (5) 19 (3) -
Musculoskeletal (% of sample) 9 (3) 26 (5) 13 (2) -
Comorbidity (% of sample)  85 (28)  100 (19)  81 (13) p=.166
Meeting the PA guidelines (% of 
sample)*
73 (22) 71 (10) 93 (13) p=.223
P-values represent between arm baseline effects. There was no between arm effect for referral reason, thus no between arm p-values are provided for referral reason 
sub groups. 
*Chief Medical Officers’ 2019 physical activity guidelines: 150 minutes of moderate-intensity physical activity per week. 
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1 revealed a significantly higher CRF change in Co-PARS (2.4) compared to the ERS (0.3; p=.021) and 
2 control (-0.6; p=.001), but no difference between the ERS and control (p=.314). A significant effect for 
3 study arm was found in change in FMD% (p=.002), with FMD% change significantly higher in Co-PARS 
4 (2.4) compared to control (-1.1; p=.001) but not the ERS (0.8; p=.099). The change in FMD% was not 
5 significantly different between the ERS and control (p=.71). No statistically significant study arm 
6 effects were noted for changes in CAR%, blood pressure, resting heart rate, anthropometric measures, 
7 PA or WEMWBS at 12 weeks (p>.05). 
8 Baseline-to-6-month effects
9 No statistically significant study arm effects were noted for change in WEMWBS or PA at 6 months 
10 (p>.05). 
11 Fitness centre engagement (Co-PARS and usual care ERS) and consultation attendance (Co-PARS 
12 only). 
13 Table 3 reports the participant fitness centre engagement data for the Co-PARS and usual care ERS. 
14 Although not statistically significant, Co-PARS engagement was 9% higher, participants attended the 
15 fitness centre on average 3 times more per month, and 23% more participants were attending the 
16 fitness centre beyond 6-months follow-up compared to usual care. Co-PARS behaviour change 
17 consultation attendance is reported in Table 4.
18
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Table 2. Cardiometabolic health outcomes and PA levels at baseline, 12 weeks, 6 months, and between arm baseline-to 12-week or 6-month 
effect.  All variables are presented as Mean  SD.
Co-PARS Usual Care ERS No-Treatment Control
Baseline Week 12 6 Month Baseline Week 12 6 Month Baseline Week 12 6 Month Between arm effect p-value(a)
Fitness (n=56)
CRF  ml.kg.-1min-1 22.27 24.67 - 23.36.6 23.67 - 29.69.2 28.98.7 - p=.002
Physical Activity
GT3x (n= 61) Mins.day
Light intensity 9052 9864 10775 9836 9331 158145 9037 10133 8640 p=.332
Moderate intensity 4432 4229 4233 4328 4330 5555 6031 6524 5421 p=.260
Vigorous intensity 13 12 12 12 11 12 24 23 38 p=.108
Vascular Ultrasound (n=64)
CAR% 1.72.7 2.82.2 - 2.71.8 3.92.8 - 2.52.7 1.72.7 - p=.073
CAR Baseline cm 0.690.07 0.690.06 - 0.690.08 0.70.09 - 0.650.07 0.640.06 - p=.130
FMD% 4.42.3 6.82.7 - 4.22 52.1 - 6.22.1 5.22.8 - p=.002
FMD Baseline  cm 0.390.07 0.380.06 - 0.390.09 0.41 0.08 - 0.380.08 0.370.06 - p=.728
Cardiometabolic (n=68)
BMI kg.m2 317 307 - 336 326 - 296 296 - p=.323
WHR 629 6110 - 648 638 - 569 569 - p=.261
SBP mmHg 13111 12712 - 13818 13215 - 12312 11813 - p=.937
DBP  mmHg 737 718 - 739 7111 - 7211 6810 - p=.584
RHR bpm 7010 6510 7012 6811 6612 639 p=.540
Mental Wellbeing (n=68)
WEMWBS 469 5110 4810 4910 5211 5013 539 569 5310 p=.796
 Co-PARS, Co-produced PA referral scheme; ERS, Exercise referral scheme; CRF, Cardiorespiratory Fitness; GT3x, Accelerometer; CAR, Carotid artery reactivity; FMD, Flow-mediated dilation; BMI, Body Mass Index; WHR, 
Waist-to-Height ratio;  SBP, Systolic blood pressure; DBP, Diastolic blood pressure; RHR, Resting heart rate, WEMWBS, Warwick-Edinburgh Mental Wellbeing Scale
a F-statistic for between arm baseline-to-6-month change or baseline-to-week 12 change if variable not collected at 6 months.
Missing data was due to inability to complete the CRF test (n=12), inability to complete the vascular ultrasound protocols (n=4), and insufficient accelerometer wear time or non-return (n=7). 
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Table 3. Fitness centre engagement.
 Co-PARS
(n=33)
Usual Care
(n=19)
Between centre difference
% Engagementa  (Mean  SD) 42±29 33±27 p=.267
Number of fitness centre visits (per person  
per month) week 12 to 6 months (Med, IQR)
3(0-14) 0 (0-1) p=.072
% of baseline sample who attended fitness 
centre at least once beyond 6 months (% of 
sample, n)
39 (13) 16 (3) p=.101
aBased on the formula (((n1*0.5)+(n2)+(n3*1.2))/12) * 100; n1=number of weeks in which participant attends once only; n2=number of weeks in which 
participant attends twice; n3=number of weeks in which participant attends three or more times.  aEngagement;.based on a recommended attendance 
of twice weekly, a formula was used to calculate a percentage for “12-week engagement”, which took into account both frequency and consistency of 
attendance (see methods). 
Table 4. Co-PARS behaviour change consultation attendance (based on baseline sample of 33 
participants).
Consultation % Booked (n) % Attended (n)
Induction 91(30) 93(28)
Week 4 82(27) 78(21)
Week 8 67(22) 91(20)
Week 12 64(21) 81(17)
Week 18 55(18) 50(9)
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1 DISCUSSION
2 This was the first study to investigate the effectiveness of a theoretically-grounded, co-produced PA 
3 referral scheme (Co-PARS) compared to a usual care ERS and no treatment. Despite challenges in 
4 recruitment that meant the study was statistically underpowered, the findings demonstrated 
5 significant and clinically meaningful improvements in CRF and vascular health in Co-PARS compared 
6 to the usual care and no treatment. No statistically significant effects were noted for accelerometer-
7 derived PA levels or mental wellbeing at 12-weeks or 6-months. 
8 The effect of usual care ERSs compared to theoretically-grounded interventions on CRF has not been 
9 previously explored. We observed a significant increase in CRF in Co-PARS compared to usual care and 
10 a no-treatment control. According to values reported by Clausen et al. [42] both Co-PARS (22 ml.kg.-
11 1min-1) and usual care (23 ml.kg.-1min-1) participants were below the lower limit of ‘healthy’ (27.7 
12 ml.kg.-1min-1) for baseline CRF [43]. As low CRF is associated with a substantially elevated risk of all-
13 cause mortality [43], the magnitude of change demonstrated in Co-PARS (2.4 ml.kg.-1min-1) may be 
14 clinically meaningful. For example, in at-risk populations, relatively small magnitudes (≤1 ml.kg.-1min-
15 1) have been shown to significantly reduce clustered cardiometabolic risk [44]. Thus, Co-PARS was 
16 effective at improving CRF in individuals with low CRF by a clinically meaningful amount.
17 Promising improvements in vascular health were also noted in the Co-PARS group, with brachial artery 
18 FMD significantly improved compared to usual care and control arms. Although CAR was not 
19 statistically different between arms, both Co-PARS and usual care demonstrated a potentially 
20 meaningful within-arm improvement compared with no treatment, which exhibited a deterioration in 
21 vascular health. Such improvements in vascular measures may have prognostic implications. For 
22 example, a 1% increase in FMD has been suggested to reduce the future risk of CVD events by 13% 
23 [36].
24 Despite low baseline CRF, a substantial percentage of Co-PARS (73%) and usual care (71%) participants 
25 were meeting the Department of Health [45] guidelines of 150 minutes of moderate-intensity PA per 
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1 week. We observed a similar finding in our pilot [26] and subsequently raised the question as to the 
2 use of PA guidelines to assess eligibility for ERSs (NICE, 2014), as it appears from our data that 
3 individuals classified as “physically active” can still be very unfit and therefore can benefit from ERSs 
4 in terms of improved fitness and cardiometabolic health. A further discrepancy was noted in the lack 
5 of change in PA levels in Co-PARS, despite improved CRF. It is possible measurement issues 
6 contributed to this discrepancy. Accelerometers can measure certain types of PA such as walking, 
7 running, and stair climbing [46]. They may not, however, sufficiently identify activities typical of an 
8 ERS delivered within a fitness centre environment (e.g. cycling, resistance training, circuits, 
9 swimming). Given Co-PARS had higher (albeit non-significant) fitness centre engagement compared 
10 to usual care, it is possible PA changes occurred that were not detected by the accelerometry data. 
11 Consideration therefore needs to be given to the appropriateness of accelerometers to measure PA 
12 in ERSs.  Alternative methods such as heart-rate monitors combined with self-report data may be 
13 worthy of consideration, although further work would be required to develop standardized data 
14 collection and analysis protocols (taking into account the limitations of each of these methods if used 
15 in isolation [47]).  Researchers are therefore urged to consider CRF as a primary outcome in ERSs until 
16 appropriate alternative methods of measuring PA behaviour are developed. Ultimately, it is not clear 
17 why the increase in fitness occurred without a corresponding change in PA and further research is 
18 required to elucidate the relationship between PA and fitness in this population. 
19 In addition to physiological health outcomes, we found baseline mental wellbeing to be below the 
20 national average (score of 50) in both Co-PARS (46) and usual care (49), but not the control (53) [48]. 
21 Despite no significant between-group effect for mental wellbeing, within-group changes at 12 weeks 
22 were deemed clinically meaningful for Co-PARS (5) and usual care (3) but not in the no treatment 
23 control. It is notable that the post-intervention magnitude of change observed in mental wellbeing for 
24 Co-PARS (5) was larger than that observed in a meta-analysis encompassing >23,000 participants 
25 across 13 different ERSs (3), which were comparable in nature to the usual care ERS in this study [49].
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1 From the 6-month data it appeared the scheme was not effective at promoting sustained PA behaviour 
2 change or mental wellbeing improvements. It must be noted, however, that the wellbeing levels were 
3 still higher than baseline and even small magnitudes of change (1-3) may be meaningful in clinical 
4 populations [50]. As discussed earlier, it may be that measuring PA using the methods described in 
5 this study prevented the identification of activities typical of a fitness centre environment. This notion 
6 is supported by the post-week-12 attendance data, which highlighted Co-PARS participants were 
7 regularly attending the fitness centre whereas the usual care participants were not. Challenges of 
8 maintaining sustained health outcomes post-ERSs have been highlighted elsewhere [3]. And whilst a 
9 recent systematic review reported longer length schemes (>20 weeks) may be more effective than 
10 shorter schemes [8], the four long ERSs (20-26 weeks) collected pre-post data only. Thus we do not 
11 know if longer length ERSs result in enhanced health outcomes post intervention compared with 
12 shorter schemes. To determine if longer length schemes are indeed more effective, longer-term 
13 follow-up data collection is required, ideally at 6 and 12 months post intervention [51]. 
14 Through a phased approach we have assessed the effectiveness of Co-PARS resulting from several 
15 years of co-production. Whilst the effects of co-production are difficult to isolate, a comparison of 
16 results at different stages of intervention refinement suggests the phased development approach had 
17 some positive effects. Unpublished engagement data from centre A in 2014-2015 (when the centre 
18 was running a usual care ERS) shows that engagement improved after the introduction of Co-PARS 
19 (42% vs 28% in 2014-2015), whereas engagement reduced in the usual care centre over the same 
20 period (32% vs 37% in 2014-2015).  Furthermore, consultation attendance for Co-PARS in the current 
21 study was substantially higher than in our previous pilot (54% attended induction plus ≥3 behaviour 
22 change consultations, vs 9% in the pilot [26]), which may have been a reflection of refinements made 
23 to the intervention after the pilot (e.g. improved focus on holistic PA, improved monitoring 
24 procedures, improved continuity of instructors). These improvements in engagement highlight the 
25 importance of allowing time for complex interventions to develop [52], and are particularly promising 
26 given the effectiveness of ERSs are highly dependent on participant adherence [5,21]. Furthermore, 
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1 this study has demonstrated how investing in the “bottom-up” development of an intervention can 
2 lead to an effective and sustainable model. We therefore support the arguments of Rutter and 
3 colleagues [53] in that a shift in thinking is needed, instead of asking whether an intervention works 
4 to fix a problem, researchers should aim to identify if and how it contributes to reshaping a system in 
5 a favourable way. As such, we propose the co-production and implementation process may be as 
6 important as the scheme content itself.
7 Methodological considerations
8 This is the first known study to investigate the effectiveness of a co-produced PA referral scheme (Co-
9 PARS) in comparison to usual care and a no-treatment control. Our novel approach addresses an 
10 important gap in the sport and exercise medicine literature [54], in that we employed rigorous 
11 laboratory-based instruments to measure  health outcomes that can be achieved through an 
12 ecologically valid, “real-world” intervention. We observed a very high retention at 6-month follow up, 
13 which may be due in part to the fact many of the participants were retired (and therefore may have 
14 more available time). It is possible also that the high retention was facilitated by the co-production 
15 process, which involved ongoing relationships between the research and delivery teams (and 
16 therefore helped with the logistics of returning accelerometers for the co-PARS and usual care 
17 groups). Whilst this paper highlights many strengths of co-production, we do not wish to present co-
18 production as a panacea [19] and it is important potential challenges and costs are considered prior 
19 to undertaking such an approach [21,22].
20 We must acknowledge some limitations of the study.  Whilst there is a need for high-quality RCTs of 
21 theoretically informed approaches to PA behaviour change [3],  several pragmatic reasons meant an 
22 RCT approach was not appropriate for the present study. Firstly, it was important participants could 
23 choose the most convenient fitness centre. Secondly, it was important we continued work with the 
24 same fitness centre and staff (following co-production [23] and pilot [26] phases) in order to develop 
25 the intervention to the point where it was deemed to have a worthwhile effect [52]. A pragmatic 
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1 research approach was therefore deemed most appropriate to evaluate Co-PARS with high ecological 
2 validity. Pragmatic constraints (e.g. fitness centre refurbishments, staff illness) did however mean the 
3 required sample size was not achieved, thus inferences of effectiveness need to be taken with caution. 
4 This is particularly true for the PA data, where the relatively high variability (compared with CRF) may 
5 have contributed to the lack of change observed in PA in this study. It is recommended future work 
6 considers pragmatic risks and contingencies when planning recruitment and plans sufficient time to 
7 cope with recruitment delays. For pragmatic reasons, not all outcomes were collected at 6-months 
8 follow-up and further research is needed to collect long-term, objective health data following PA 
9 referral schemes.  Finally, it must be noted that while the trial registration appears to be retrospective 
10 (April 6th 2018), the initial submission was several months prior to this (January 11th 2018).  Final sign-
11 off was delayed due to capacity issues within the research team.   
12 CONCLUSION
13 A co-produced, theoretically-grounded PA referral scheme (Co-PARS) led to improved CRF and 
14 vascular health in at-risk individuals when compared to usual care and no treatment. In addition, 
15 clinically meaningful improvements in vascular health and mental wellbeing were observed at 12-
16 weeks in both Co-PARS and usual care, but not the no treatment control group. Of note, PA remained 
17 unchanged at 12-weeks and 6-months follow-up. Adopting a phased approach has enabled multi-
18 stakeholder input and ongoing intervention refinement, resulting in an intervention that showed 
19 promising effects on engagement and clinically meaningful improvements to participant health.  
20
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1 Figure Legends
2 Figure 1. ‘PaT Plot’ describing intervention arm components.[55] 
3 Figure 2. Participant flow diagram within the three study arms (March 2018-January 2019). 
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Figure 1. PaT Plot’ describing intervention arm components. 
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Lost to follow up (n= 2) 
 
Included in analyses following 
intention-to-treat protocol (n= 16) 
 
Completed 6-month testing (n= 28) Completed 6-month testing (n= 16) 
 
Completed 6-month testing (n= 14) 
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Reported?Paper 
Section/Topic 
Item 
No. Descriptor  Pg #
TITLE and ABSTRACT
Title and Abstract 1  Information on how units were allocated to interventions ✓ 1,2
 Structured abstract recommended ✓ 2
 Information on target population or study sample ✓ 2
INTRODUCTION
Background 2  Scientific background and explanation of rationale ✓ 4-5
 Theories used in designing behavioral interventions ✓ 6
METHODS 
Participants 3  Eligibility criteria for participants, including criteria at different levels in recruitment/sampling plan (e.g., cities, 
clinics, subjects)
✓ 5-6
 Method of recruitment (e.g., referral, self-selection), including the sampling method if a systematic sampling 
plan was implemented
✓ 5-6
 Recruitment setting ✓ 6,7
 Settings and locations where the data were collected ✓ 5-6
Interventions 4  Details of the interventions intended for each study condition and how and when they were actually 
administered, specifically including:
✓ 6-8
o Content: what was given? ✓ 6-8
o Delivery method: how was the content given? ✓ 6-8
o Unit of delivery: how were subjects grouped during delivery? ✓ 6-8
o Deliverer: who delivered the intervention? ✓ 6-8
o Setting: where was the intervention delivered? ✓ 6-8
o Exposure quantity and duration: how many sessions or episodes or events were intended to be delivered? 
How long were they intended to last? 
✓ 6-8
o Time span: how long was it intended to take to deliver the intervention to each unit? ✓ 6-8
o Activities to increase compliance or adherence (e.g., incentives) N/A
Objectives 5  Specific objectives and hypotheses ✓ 5
Outcomes 6  Clearly defined primary and secondary outcome measures ✓ 7-8
 Methods used to collect data and any methods used to enhance the quality of measurements ✓ 7-8
 Information on validated instruments such as psychometric and biometric properties N/A
Sample size 7  How sample size was determined and, when applicable, explanation of any interim analyses and stopping 
rules
✓ 8
8  Unit of assignment (the unit being assigned to study condition, e.g., individual, group, community) N/A
 Method used to assign units to study conditions, including details of any restriction (e.g., blocking, 
stratification, minimization) N/A
Assignment 
method
 Inclusion of aspects employed to help minimize potential bias induced due to non-randomization (e.g., 
matching) N/A
Blinding (masking) 9  Whether or not participants, those administering the interventions, and those assessing the outcomes were 
blinded to study condition assignment; if so, statement regarding how the blinding was accomplished and how 
it was assessed
N/A
Unit of Analysis 10  Description of the smallest unit that is being analysed to assess intervention effects (e.g., individual, group, or 
community) 
✓ 8-9
 If the unit of analysis differs from the unit of assignment, the analytical method used to account for this (e.g., 
adjusting the standard error estimates by the design effect or using multilevel analysis) N/A
 Statistical methods used to compare study groups for primary methods outcome(s), including complex 
methods for correlated data
✓ 8-9
 Statistical methods used for additional analyses, such as subgroup analyses and adjusted analysis ✓ 8-9
Statistical 
methods
11
 Methods for imputing missing data, if used N/A
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TREND Statement Checklist
 Statistical software or programs used ✓ 8-9
RESULTS 
Participant flow 12  Flow of participants through each stage of the study: enrollment, assignment, allocation and intervention 
exposure, follow-up, analysis (a diagram is strongly recommended)
✓ 9
o Enrollment: the numbers of participants screened for eligibility, found to be eligible or not eligible, declined 
to be enrolled, and enrolled in the study
✓ 9
o Assignment: the numbers of participants assigned to a study condition ✓ 9
o Allocation and intervention exposure: the number of participants assigned to each study condition and the 
number of participants who received each intervention
✓ 9
o Follow-up: the number of participants who completed the follow-up or did not complete the follow-up (i.e., 
lost to follow-up), by study condition
✓ 9
o Analysis: the number of participants included in or excluded from the main analysis, by study condition ✓ 9
 Description of protocol deviations from study as planned, along with reasons N/A
Recruitment 13  Dates defining the periods of recruitment and follow-up ✓ 9
Baseline data 14  Baseline demographic and clinical characteristics of participants in each study condition ✓ 10
 Baseline characteristics for each study condition relevant to specific disease prevention research ✓ 10
 Baseline comparisons of those lost to follow-up and those retained, overall and by study condition N/A
 Comparison between study population at baseline and target population of interest N/A
Baseline 
equivalence
15  Data on study group equivalence at baseline and statistical methods used to control for baseline differences N/A
Numbers 
analyzed
16  Number of participants (denominator) included in each analysis for each study condition, particularly when the 
denominators change for different outcomes; statement of the results in absolute numbers when feasible
✓ 10-13
 Indication of whether the analysis strategy was “intention to treat” or, if not, description of how non-compliers 
were treated in the analyses
✓ 8-9
Outcomes and 
estimation
17  For each primary and secondary outcome, a summary of results for each estimation study condition, and the 
estimated effect size and a confidence interval to indicate the precision
✓ 10
 Inclusion of null and negative findings ✓ 10
 Inclusion of results from testing pre-specified causal pathways through which the intervention was intended to 
operate, if any N/A
Ancillary analyses 18  Summary of other analyses performed, including subgroup or restricted analyses, indicating which are pre-
specified or exploratory N/A
Adverse events 19  Summary of all important adverse events or unintended effects in each study condition (including summary 
measures, effect size estimates, and confidence intervals)
✓ 10
DISCUSSION 
Interpretation 20  Interpretation of the results, taking into account study hypotheses, sources of potential bias, imprecision of 
measures, multiplicative analyses, and other limitations or weaknesses of the study
✓ 14-17
 Discussion of results taking into account the mechanism by which the intervention was intended to work 
(causal pathways) or alternative mechanisms or explanations ✓ 14-17
 Discussion of the success of and barriers to implementing the intervention, fidelity of implementation ✓ 14-17
 Discussion of research, programmatic, or policy implications ✓ 14-17
Generalizability 21  Generalizability (external validity) of the trial findings, taking into account the study population, the 
characteristics of the intervention, length of follow-up, incentives, compliance rates, specific sites/settings 
involved in the study, and other contextual issues
✓ 14-17
Overall evidence 22  General interpretation of the results in the context of current evidence and current theory ✓ 14-17
From:  Des Jarlais, D. C., Lyles, C., Crepaz, N., & the Trend Group (2004). Improving the reporting quality of nonrandomized evaluations of 
behavioral and public health interventions: The TREND statement. American Journal of Public Health, 94, 361-366.  For more information, visit: 
http://www.cdc.gov/trendstatement/
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